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Abbreviations 
 AGP α-1-acid glycoprotein 
CRP C-reactive protein 
F female 
IL interleukin 
LOD limit of detection 
M male 
MCH mean corpuscular hemoglobin 
MCV mean corpuscular volume 
sTFR soluble transferrin receptor 
TIBC total iron binding capacity 
TSAT transferrin saturation,  
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Abstract 
 
The present study aimed to quantify the magnitude of the systemic inflammatory 
response, measured by C-reactive protein (CRP) and albumin, and its  relationship 
with common serum biochemical measures of iron status including total iron, 
transferrin, transferrin saturation and ferritin.  Retrospective interrogation of  
laboratory computer databases at 4 centres between 2006 and 2011 provided results 
from patients in which serum CRP and albumin had been measured together with iron 
studies (iron, transferrin and transferrin saturation, n=16,522) and ferritin (n=7,226).  
Analyte results were categorized into groups according to CRP and albumin.  When 
those groups with CRP <10mg/L and albumin >35g/L, CRP11-80mg/L and albumin 
25-35mg/L, and CRP >80mg/L and albumin <25g/L were compared, the median 
serum total iron was 15.0, 7.0 and 3.0 μmol/L respectively (p<0.001), an overall 
reduction of 80%.  The median serum transferrin concentration was 2.6, 2.0 and 1.3 
μmol/L respectively (p<0.001), an overall reduction of 50%.  The median transferrin 
saturation was 23%, 13% and 10% respectively (p<0.001), an overall reduction of 
56%.  The median serum ferritin was 77, 173 and 445 μg/L respectively (p<0.001), an 
overall increase of 578%.  The present study quantifies the impact of the systemic 
inflammatory response on serum measures of iron status.  This association should be 
taken into account when measures of iron status are requested and interpreted to 
prevent misdiagnosis. 
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Introduction 
 
The gold standard assessment of iron status is considered to be microscopy of a bone 
marrow trephine sample, however, this is a painful and invasive procedure.
1
  There 
are a number of serum analytes proposed for the assessment of iron status. These 
include iron itself, proteins involved in its metabolism such as transferrin, ferritin, 
soluble transferrin receptor (sTFR) and zinc protoporphyrin, and derived values such 
as transferrin saturation (TSAT) and total iron binding capacity (TIBC).
2
 
There is evidence that the presence of systemic inflammation is associated 
with decreased serum concentrations of iron and transferrin, which are negative acute 
phase reactants.
3
  In contrast, ferritin is a positive acute phase protein and its serum 
concentrations rise in the presence of systemic inflammation.
4
  Indeed, current WHO 
guidance on assessment, and interventions in iron status recommend that the presence 
of inflammation be considered when ferritin levels are measured in those who are 
apparently well.
5
  However, the magnitude of the impact is not well quantified in 
patients. 
There is increasing evidence that the presence of a systemic inflammatory 
response confounds the interpretation of a number of serum micronutrients.
6
  Indeed, 
recent studies have quantified the impact of the systemic inflammatory response, as 
evidenced by both serum C-reactive protein (CRP) and albumin, on serum vitamins 
and micronutrients.
7-8
  With reference to iron status, hepcidin is a key regulator of iron 
homeostasis, acting to reduce iron export and cause sequestration of iron through the 
inhibition of  ferroportin.
9
  It is thought that hepcidin synthesis is influenced by 
cytokines such as interleukin 6 (IL 6), which promotes iron uptake by cells of the 
innate immune system.
10
  Similar to hepcidin, the synthesis of CRP by hepatocytes is 
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driven by circulating IL 6.
11 
 In addition, albumin, although it is not directly involved 
in iron transport, is quantitatively the most important circulating binding protein, and 
is itself a negative acute phase protein commonly measured in clinical practice.
12
   
Therefore the aim of the present study was to quantify the impact of the 
magnitude of systemic inflammation, as evidenced by CRP and albumin, on 
commonly measured serum biochemical measures of iron status.  Furthermore the 
study was carried out with the aim of developing local guidelines for the 
interpretation of serum measurements of iron status. 
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Materials and Methods 
Patients: 
Details of all requests for iron studies (total iron, transferrin, and derived transferrin 
saturation) and ferritin were obtained from the biochemistry and haematology 
laboratory information systems of 4 Glasgow hospitals respectively for the period 1
st
 
August 2006 to 31
st
 July 2011.  These requests were made from secondary inpatient, 
secondary outpatient and primary care healthcare providers.  Iron study and ferritin 
results were matched to CRP and albumin results obtained on the same calendar day 
using electronic  laboratory  patient identifiers. Any iron study requests which were 
not accompanied by a CRP and albumin request were not included in the study. 
Where an individual had repeat measurements, only the first was included in the 
study. 
Two groups were obtained: a large cohort of patients who had iron study 
measurement, including total iron and transferrin results (n=16,522), and a smaller 
cohort of patients who had ferritin results (n=7,226). The dataset of ferritin results 
was not a subset of the larger iron study dataset. 
The audit was conducted with the intent of developing local guidelines and to 
aid in the interpretation of serum measurements of iron status and was approved by 
NHS Greater Glasgow and Clyde . 
 
 
Methods: 
Serum total iron (chemically using ferene), transferrin (by the immunoturbidimetric 
method),  CRP (by the immunoturbidimetric method) and albumin (chemically using 
Bromocresol purple) were measured using an automated analyser (Architect, Abbot 
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Diagnosis, Maidenhead, UK) in the routine biochemistry laboratories.  Ferritin was 
analysed using 2 step chemiluminescent microparticle immunoassay within the 
routine haematology laboratories.  All sites used the same analytic materials and 
automated platforms.  There were no sustained concerns regarding IQC performance 
requiring investigation into the performance of the assays. The A, B and C scores 
were within the EQA (NEQAS) targets during the study period.  Transferrin 
saturation was calculated empirically from serum total iron and transferrin by each 
laboratory as (4 * [Fe] nmol/L) / (Transferrin mg/L) assuming 2 iron molecules bind 
to one transferrin molecule.  Although the theoretical problems with this method are 
noted, this was the calculation used in all laboratories during the study period.
13
   
Where a calculated transferrin saturation result was not available as either the iron or 
transferrin results were below the limit of detection (LOD, <2μmol/L and <0.2g/L 
respectively), the results below the LOD for transferrin saturation was estimated by 
substituting the absolute value of the LOD. 
 
 
Statistical analysis: 
Data was presented as median and ranges.  Correlations between variables were 
carried out using Spearman’s rank method (rs).  The cohorts were divided into groups 
according to CRP (<10, 10-80, >80mg/L) and albumin concentrations (<25, 25-35, 
>35 g/L) as previously described.
8, 14-15
  Furthermore, from these initial groupings, 3 
groups with minimal (group 1, CRP <10mg/L and albumin >35g/L), moderate (group 
2, CRP 10-80mg/L and albumin 25-35g/L) and maximal (group 3 CRP >80mg/L and 
albumin <25g/L) systemic inflammation were identified.  The distribution of each 
8 
 
parameter of iron status were compared across strata of CRP and albumin using the 
Kruskal-Wallis test.   
The proportion of individuals with results outside the laboratory reference 
ranges of serum total iron (10-30 μmol/L) and transferrin (2.0-4.0 g/L) was calculated 
and compared using the χ2 test for linear association.  The proportion of individuals in 
each stratum meeting common criteria for iron deficiency or excess as defined by 
serum transferrin saturation and ferritin was calculated and compared using the χ2 test 
for linear association.   Cut off values for iron deficiency normally applied to patients 
without inflammation were; transferrin saturation <10%, and ferritin <15μg/L.16  Cut 
off values for iron excess normally applied to patients without inflammation were; 
transferrin saturation >55% in males or >50% in females, ferritin >300μg/L in males 
or >200μg/L in females.17   
P values <0.05 were considered statistically significant.  Statistical analyses 
were performed using IBM SPSS version 22 for Windows (Chicago, IL, USA).    
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Results 
Patients: 
During the study period there were 16,522 patients (F/M: 56%/44%; median age: 68; 
interquartile range: 51 to 79 years) in the iron study cohort (iron, transferrin, 
calculated transferrin saturation), and7,226patients (F/M: 55%/45%; median age: 68; 
interquartile range: 52 to 79 years) in the ferritin cohort (Table 1).  There was no 
significant difference in age (p=1.000), sex (p=0.309), median CRP (14.0mg/L vs. 
15mg/L, p=0.248) or median albumin (33g/L vs. 32 g/L, p=0.980) when the two 
cohorts were compared.  It did not therefore influence further the way in which the 
data was analysed. 
All iron status measures were significantly associated with CRP, and albumin 
(Table 2).  There was a significant inverse  correlation between age and iron (rs=-
0.301, p<0.001)), transferrin (rs=-0.161, p<0.001), transferrin saturation (rs=-0.237, 
p<0.001), and ferritin (rs=-0.023, p=0.047) for the sexes combined.  When the sexes 
were compared, there was a small but statistically significant  difference in median 
iron (M=9.0μmol/L, F=8.0μmol/L, p<0.001), transferrin (M=2.00g/L, F=2.20g/L, 
p<0.001), transferrin saturation (M=19%, F=15%, p<0.001), and ferritin 
(M=233μg/L, F=115μg/L).   
 
Serum Total Iron: 
Serum total iron was significantly inversely correlated with CRP (rs=-0.554, p<0.001) 
and positively correlated with albumin (rs=0.907, p<0.001).  When systemic 
inflammation groups 1 (CRP  <10mg/L and albumin >35g/L), 2 (CRP 11-80mg/L and 
albumin 25-35mg/L), and 3 (CRP >80mg/L and albumin <25g/L) were compared 
(Table 3), the median serum total iron was 15.0, 7.0 and 3.0 μmol/L respectively 
10 
 
(p<0.001) with group 3 having a median serum total iron 80% lower than that of 
group 1.  When systemic inflammation groups 1, 2 and 3 were compared, there was a 
significant difference in the proportion of patients with serum total iron below (<10 
μmol/L, 29%, 76% and 93% respectively, p<0.001) or above (>30 μmol/L, 8%, 2% 
and 1% respectively, p<0.001) the reference range. 
 
Transferrin: 
Serum transferrin was significantly inversely correlated with CRP (rs=-0.511, 
p<0.001) and positively correlated with albumin (rs=0.679, p<0.001).  When systemic 
inflammation groups 1 (CRP <10mg/L and albumin >35g/L), 2 (CRP 11-80mg/L and 
albumin 25-35mg/L), and 2 (CRP >80mg/L and albumin <25g/L) were compared 
(Table 4), the median serum transferrin concentration was 2.6, 2.0 and 1.3 g/L 
respectively (p<0.001) with group 3 having a median serum transferrin 50% lower 
than that of group 1.  When systemic inflammation groups 1, 2 and 3 were compared, 
there was a significant difference in the proportion of patients with serum transferrin 
below (<2.0 g/L, 12%, 54% and 96% respectively, p<0.001) or above (>4.0 g/L, 2%, 
0% and 0% respectively, p<0.001) the reference range. 
 
Transferrin saturation: 
Transferrin saturation was significantly inversely correlated with CRP (rs=-0.349, 
p<0.001) and positively correlated with albumin (rs=0.161, p<0.001). When systemic 
inflammation groups 1 (CRP <10mg/L and albumin >35g/L), 2 (CRP 11-80mg/L and 
albumin 25-35mg/L), and 3 (CRP >80mg/L and albumin <25g/L) were compared 
(Table 5), the median transferrin saturation was 23%, 13% and 10% respectively 
(p<0.001) with group 3 having a median transferrin saturation 56% lower than that of 
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group 1. When systemic inflammation groups 1, 2 and 3 were compared, there was a 
significant difference in the proportion of patients meeting criteria for iron deficiency 
(TSAT <10%, 15%, 39% and 53% respectively, p<0.001) or iron excess (TSAT 
M>55% F>50%, 7%, 5% and 5% respectively, p<0.001). 
 
Ferritin: 
Serum ferritin was significantly positively correlated with CRP (rs=0.396, p<0.001) 
and inversely correlated with albumin (rs=-0.383, p<0.001). When systemic 
inflammation groups 1 (CRP <10mg/L and albumin >35g/L), 2 (CRP 11-80mg/L and 
albumin 25-35mg/L), and 2 (CRP >80mg/L and albumin <25g/L) were compared 
(Table 6), the median serum ferritin was 77, 173 and 445 μg/L respectively (p<0.001) 
with group 3 having a median serum ferritin 578% higher than that of group 1. When 
systemic inflammation groups 1, 2 and 3 were compared, there was a significant 
difference in the proportion of patients meeting criteria for iron deficiency (<15 μg/L, 
13%, 3% and 0% respectively, p=0.001) or iron excess (M>300 μg/L F>50 μg/L, 
21%, 38% and 75% respectively, p<0.001). 
 
 
 
 
 
 
 
 
 
12 
 
Discussion 
The results of the present study show that serum measures of iron status, iron, 
transferrin, transferrin saturation and ferritin are significantly and independently 
associated with CRP and albumin.  Serum total iron, transferrin and ferritin 
concentrations were particularly sensitive to CRP and albumin concentrations outside 
the normal ranges, such that there was a synergistic impact on these measures of iron 
status.  A clear conclusion is that determining the iron status of patients with acute or 
ongoing systemic inflammation using these serum measures is problematic.   
 Indeed, according to the results of the present study, many patients with CRP 
and albumin concentrations outside the normal range would meet diagnostic criteria 
for iron deficiency by iron and transferrin saturation but would also meet criteria for 
iron overload as measured by serum ferritin.
5
  The clinical implications are profound, 
for example based on such serum measures there may be inappropriate use of iron 
replacement therapy or blood transfusion in those with systemic inflammation during 
medical or surgical care.  Therefore, given external validation of these findings, the 
possibility of the presence of systemic inflammation should be considered in all 
patients for whom iron status tests are requested to allow health care practitioners to 
appropriately diagnose iron deficiency or excess. 
It is also of interest that some studies have reported a significant association 
between serum measures of iron status such as transferrin saturation and ferritin, and 
increased mortality from any cause, cancer and cardiovascular disease.
18-19
  Given that 
CRP and albumin also predict mortality from any cause, cancer, cardiovascular 
disease and cerebrovascular causes, it may be that the association of measures of iron 
status and mortality is dependent on the presence of systemic inflammation.
20
  Further 
work is required to test this hypothesis.  
13 
 
In the present study, serum CRP and albumin were used as they are routine, 
clinically available measures of the magnitude of systemic inflammation, however 
there are other markers of inflammation that are used in clinical practice.  Where there 
is a chronic inflammatory state, iron status can be determined using  indices that 
directly describe the erythrocyte population, such as hemoglobin concentration, mean 
corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), or peripheral 
blood film microscopy.
21
    It is well understood that erythropoiesis is affected by both 
chronic and acute inflammation however the above indices are less subject to rapid 
change than acute phase proteins and are less likely to be useful in acute systemic 
inflammation.
9 
Platelets are also routinely measured as part of a full blood count 
(FBC).  Indeed, thrombocytosis is well recognised to be associated with both systemic 
inflammation and iron deficiency.
22-23
  Components of the differential white cell count 
including a variety of ratios derived from neutrophils, monocytes and lymphocytes 
have been of interest, particularly in the setting of clinical oncology.
24-25
 However 
relationships between these ratios, such as the neutrophil lymphocyte ratio (NLR) and 
lymphocyte monocyte ratio (LMR) and iron status are unclear.   
Serum procalcitonin concentrations have been used in clinical practice to 
identify the presence of bacterial infection in particular, especially in the critical care 
setting, however to our knowledge the relationship between procalcitonin and 
measures of iron status has not been examined.
26
  Theses markers of the systemic 
inflammation response do not readily differentiate the source of inflammation and 
their interpretation is dependent on the clinical context.  There is also increasing 
interest in the use of soluble transferrin receptor (sTFR) in the assessment of iron 
status as it is less affected by systemic inflammation.
27
  The use of the sTFR/log 
14 
 
ferritin index has also been proposed.
28
  However, at present sTFR is not widely 
available in UK clinical practice, and is subject to substantial biological variability.
29
 
 
A potential limitation of the present study is the lack of clinical data regarding 
reasons for the investigation of iron status in the included patients.  In particular, other 
than that of albumin, there were no clinical data relating to the presence of liver 
disease or markers of synthetic liver function which is associated with altered iron 
homeostasis.  However, given the large number of patients in the cohorts analysed in 
the present study it would be unlikely that the associations identified were due to the 
sampling of a specific population.. The consistent trends of progressive changes in 
analyte concentration with differing CRP and albumin provide convincing evidence of 
the  association between inflammation  and these measures.  Moreover, these 
observations can be readily externally validated. 
 The present study demonstrates a significant association between commonly 
measured serum biochemical measures of iron status and the magnitude of systemic 
inflammation as measured by serum CRP and albumin.  This association should be 
taken into account when measures of iron status are requested and interpreted to avoid 
misdiagnosis.  However, given the relative variability of the association between the 
systemic inflammatory response and these serum measures of iron status, attempts to 
mathematically correct for it using regression equations for CRP and albumin are 
likely to prove relatively inaccurate.  It may be that in future, assays less influenced 
by systemic inflammation, e.g. soluble transferrin receptors, will be routinely 
available to reliably diagnose states of iron deficiency or excess in patients referred 
for iron status assessment.  Furthermore, if there is evidence of systemic 
15 
 
inflammation, the serum measure of iron status assessed in the present study should 
not be used to routinely assess iron status. 
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Tables and footnotes: 
 
 
Table 1: Characteristics of patients in iron studies and ferritin cohorts 
 
 
Table 2: Correlation between serum iron status measures, C-reactive protein and 
albumin 
 
Table 3: Distribution of serum Iron and proportion of patients below (<10 μmol/L) 
and above (>30 μmol/L) the reference range according to C-reactive protein and 
albumin concentrations 
 
Table 4: Distribution of serum Transferrin and proportion of patients below (<2.0 
g/L) and above (>4.0 g/L) the reference range according to C-reactive protein and 
albumin concentrations  
 
 
Table 5: Distribution of serum Transferrin saturation and proportion of patients 
meeting criteria for iron deficiency (<10%) and excess (male >55%, female >50%) 
according to C-reactive protein and albumin 
 
Table 6: Distribution of serum Ferritin and proportion of patients meeting criteria for 
iron deficiency (<15 μg/L) and excess (male >300μg/L, female >200 μg/L) according 
to C-reactive protein and albumin  
